Literature DB >> 6253670

Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus.

P R Shank, M Linial.   

Abstract

We have previously described a nonconditional mutant of avian sarcoma virus (SE21Q1b) which fails to package viral RNA (Gallis et al., Virology 94:146-161, 1979; Linial et al., Cell 15:1371-1381, 1978). Quail cells transformed by SE21Q1b contain normal amounts of intracellular viral mRNA's for src, env, and gag-pol and release particles with the density of normal virus containing a typical complement of virion proteins, including reverse transcriptase. These virions are noninfectious for both chicken and quail cells and contain primarily cellular rather than viral RNA. Analysis by gel electrophoresis of the cellular DNA of quail cells transformed by SE21Q1b after restriction endonuclease digestion indicated the presence of a single provirus. The provirus was located at one site in the genome of the host cell and was flanked by the characteristic terminally repeated sequences derived from the 3' and 5' ends of viral RNA. The only defect detected in the SE21Q1b provirus was a deletion of ca. 150 base pairs of DNA somewhere between 300 and 600 bases from the left (gag-pol) end of the provirus. Analyses of the proviral DNA of cells transformed by wild-type recombinants between SE21Q1b and leukosis viruses reveal that the recombinants no longer contain this deletion. The deletion, therefore, defines a region on the viral RNA which is required for correct packaging of the virion RNA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253670      PMCID: PMC353661     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  The genome-associated, specific RNA binding proteins of avian and mammalian type C viruses.

Authors:  A Sen; G J Todaro
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

3.  The arrangement of simian virus 40 sequences in the DNA of transformed cells.

Authors:  M Botchan; W Topp; J Sambrook
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

4.  Infection of chick cells by subgroup E viruses.

Authors:  M Linial; P E Neiman
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

5.  Transformation-defective mutants of Rous sarcoma virus with src gene deletions of varying length.

Authors:  S Kawai; P H Duesberg; H Hanafusa
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

6.  Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses.

Authors:  R A Weiss; W S Mason; P K Vogt
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  The a subunit in the RNA of transforming avian tumor viruses. I. Occurrence in different virus strains. II. Spontaneous loss resulting in nontransforming variants.

Authors:  G S Martin; P H Duesberg
Journal:  Virology       Date:  1972-02       Impact factor: 3.616

8.  Rous sarcoma virus genome is terminally redundant: the 5' sequence.

Authors:  W A Haseltine; A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

9.  Nucleotide sequence at the 5' terminus of the avian sarcoma virus genome.

Authors:  J Shine; A P Czernilofsky; R Friedrich; J M Bishop; H M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Isolation of defective mutant of avian sarcoma virus.

Authors:  S Kawai; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

View more
  73 in total

1.  A mutation in the short 5'-proximal open reading frame on Rous sarcoma virus RNA alters virus production.

Authors:  R B Petersen; A Moustakas; P B Hackett
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  Characterization of unintegrated retroviral DNA with long terminal repeat-associated cell-derived inserts.

Authors:  M M Dunn; J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Development of avian sarcoma and leukosis virus-based vector-packaging cell lines.

Authors:  A W Stoker; M J Bissell
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences.

Authors:  L Han; J S Yun; T E Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

6.  Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b.

Authors:  D J Anderson; P Lee; K L Levine; J S Sang; S A Shah; O O Yang; P R Shank; M L Linial
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

7.  Specificity of retroviral RNA packaging.

Authors:  R Aronoff; M Linial
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.

Authors:  J M Whitcomb; B A Ortiz-Conde; S H Hughes
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors.

Authors:  D Westaway; G Payne; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.